Alcobra Ltd (NASDAQ:ADHD) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 40% upturn. …
CoLucid Pharmaceuticals Inc CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) shares are on the run today after the migraine-medicine maker announced a definitive merger agreement with Eli …
U.S.
Alcobra Ltd Alcobra Ltd (NASDAQ:ADHD) lost half of its value today after announcing that the top-line results from MEASURE, the company’s second Phase …
Alcobra Ltd (NASDAQ:ADHD) disappointed investors today with the news that its MEASURE trial failed to meet its primary endpoint based on investigator assessment …
Tuesday turned out to be a nightmare for shareholders of Alcobra Ltd (NASDAQ:ADHD) after the biopharmaceutical company reported the top-line results from MEASURE, …
Alcobra Ltd (NASDAQ:ADHD) investors woke up to a rough morning after the Israeli drug maker disclosed official minutes from its meeting with the Division of Psychiatry …
The biotech world is experiencing volatility in the midst of a drug development discontinuation for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) and word from the FDA to …
The biotech world is full of news today, and analysts are accordingly prompted to share insights on Catabasis Pharmaceuticals Inc (NASDAQ:CATB) and Alcobra Ltd (NASDAQ:ADHD). …
Thursday turned out to be a nightmare for shareholders of Alcobra Ltd (NASDAQ:ADHD), after the ADHD drug maker announced that it has received verbal notice from …
